Skip to main content
profile image
Selected Works of Steven Borzak, MD, FACC
Article
Randomized Trial of an Oral Platelet Glycoprotein IIb/IIIa Antagonist, Sibrafiban, in Patients After an Acute Coronary Syndrome Results of the TIMI 12 Trial
Circulation (1998)
  • Christopher P. Cannon, Brigham and Women's Hospital
  • Carolyn H. McCabe, Harvard University
  • Steven Borzak, Henry Ford Health System
  • Timothy D. Henry, Medicine - Cardiology Division
  • Marc D. Tischler
  • Hiltrud S. Mueller, Yeshiva University
  • Robert Feldman, Munroe Regional Med Center
  • Sebastian T. Palmeri, Rutgers University
  • Kenneth Ault
  • Scott A. Hamilton, Genentech
  • Joel M. Rothman, Genentech
  • William F. Novotny, Genentech
  • Eugene Braunwald, Harvard University
Link
Disciplines
Publication Date
February 3, 1998
DOI
10.1161/01.CIR.97.4.340
Citation Information
Christopher P. Cannon, Carolyn H. McCabe, Steven Borzak, Timothy D. Henry, et al.. "Randomized Trial of an Oral Platelet Glycoprotein IIb/IIIa Antagonist, Sibrafiban, in Patients After an Acute Coronary Syndrome Results of the TIMI 12 Trial" Circulation Vol. 97 Iss. 4 (1998) p. 340 - 349
Available at: http://works.bepress.com/steven-borzak/118/